Stockscreener 앱 받기
2.04
0.00%
0.00
시간 외 거래:
2.05
0.010
+0.49%
전일 마감가:
$2.04
열려 있는:
$2.06
하루 거래량:
206.91K
Relative Volume:
0.88
시가총액:
$23.61M
수익:
$996.00K
순이익/손실:
$-6.09M
주가수익비율:
-3.8491
EPS:
-0.53
순현금흐름:
$-9.76M
1주 성능:
+25.15%
1개월 성능:
+17.24%
6개월 성능:
+74.36%
1년 성능:
+78.95%
1일 변동 폭
$1.8044
$2.14
1주일 범위
$1.58
$2.15
52주 변동 폭
$0.72
$2.15
Therapeuticsmd Inc Stock (TXMD) Company Profile
명칭
Therapeuticsmd Inc
전화
561-961-1900
주소
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
TXMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TXMD
Therapeuticsmd Inc
|
2.04 | 23.61M | 996.00K | -6.09M | -9.76M | -0.53 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-07 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-05-19 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-12-02 | 개시 | Guggenheim | Buy |
| 2019-10-17 | 개시 | H.C. Wainwright | Buy |
| 2019-04-30 | 재개 | Noble Capital Markets | Outperform |
| 2018-06-15 | 개시 | JP Morgan | Overweight |
| 2017-09-08 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-07-11 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2017-05-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2016-11-22 | 재개 | Jefferies | Buy |
| 2016-11-22 | 개시 | Oppenheimer | Outperform |
| 2016-11-07 | 재개 | Guggenheim | Buy |
| 2016-04-04 | 개시 | Goldman | Buy |
| 2015-12-08 | 재확인 | Jefferies | Buy |
| 2015-12-08 | 재확인 | Stifel | Buy |
| 2015-09-21 | 재확인 | Jefferies | Buy |
| 2015-06-09 | 개시 | Guggenheim | Buy |
| 2014-07-08 | 개시 | FBR Capital | Outperform |
| 2014-04-17 | 재확인 | Noble Financial | Buy |
| 2014-01-28 | 재확인 | Noble Financial | Buy |
모두보기
Therapeuticsmd Inc 주식(TXMD)의 최신 뉴스
TherapeuticsMD Reports Q3 2025 Financial Results - MSN
EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire
Fund Flows: Why TherapeuticsMD Inc stock could be next big winnerMarket Sentiment Review & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Slips 3.4%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch
TherapeuticsMD approves key proposals at annual meeting - MSN
TherapeuticsMD Inc. Stock Rallies 3.7%, Outperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why hedge funds are buying TherapeuticsMD Inc. stockWeekly Trade Report & Intraday High Probability Setup Alerts - Улправда
Is TherapeuticsMD Inc. stock a safe haven assetJuly 2025 Opening Moves & Target Return Focused Stock Picks - Bölüm Sonu Canavarı
Rate Cut: Will TherapeuticsMD Inc. stock deliver long term returnsEarnings Overview Report & AI Powered Market Entry Strategies - Улправда
How strong is TherapeuticsMD Inc. stock revenue growthGlobal Markets & AI Driven Stock Reports - DonanımHaber
MSN Money - MSN
TherapeuticsMD Earnings Notes - Trefis
Block Trades: How currency fluctuations impact TherapeuticsMD Inc. stock2025 Momentum Check & Advanced Technical Analysis Signals - ulpravda.ru
How supply chain issues affect TherapeuticsMD Inc. stockJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Dilution adjustment of TherapeuticsMD, Inc. – FWB:29TA - TradingView — Track All Markets
TherapeuticsMD Approves Key Proposals at Annual Meeting - TipRanks
TherapeuticsMD (NASDAQ: TXMD) investors approve 2025 votes, 640M share authorization - Stock Titan
Price to earnings ratio of TherapeuticsMD, Inc. – DUS:29TA - TradingView — Track All Markets
29TA Stock Price and Chart — DUS:29TA - TradingView — Track All Markets
TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch
TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Dip Buying: Is TherapeuticsMD Inc stock attractive for income investorsIPO Watch & AI Based Trade Execution Alerts - moha.gov.vn
With TherapeuticsMD Stock Surging, Have You Considered The Downside? - Trefis
TherapeuticsMD (TXMD) Stock Analysis Report | Financials & Insights - Benzinga
TherapeuticsMD, Inc. (TXMD) -6.3% in After-hours: Price Decline Despite Recent Results - Stocks Telegraph
Will TherapeuticsMD Inc. (29TA) stock profit from automation waveEarnings Miss & Weekly Watchlist of Top Performers - Newser
Will TherapeuticsMD Inc. (29TA) stock sustain bullish trend into 2025Trade Risk Summary & Safe Entry Zone Identification - Newser
Can TherapeuticsMD Inc. (29TA) stock test all time highsJuly 2025 Setups & Step-by-Step Trade Execution Guides - Newser
Is TherapeuticsMD Inc. stock affected by interest rate hikes - Newser
TherapeuticsMD Inc. Stock Sheds 3.9%, Underperforms Market - 富途牛牛
TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors - 富途牛牛
TherapeuticsMD Announces Pricing of Offering of Common Stock - AOL.com
TherapeuticsMD, Inc. (TXMD) 5.48% in After-hours: What’s Driving the Move? - Stocks Telegraph
TherapeuticsMD Inc Stock Analysis and ForecastCandlestick Trading Patterns & Low Risk Trading Plans - earlytimes.in
TherapeuticsMD Inc. Stock Falls 7.9%, Underperforms Market - 富途牛牛
What drives TherapeuticsMD Inc 29TA stock priceSupport Zone Identification & High Return Stock Ideas - earlytimes.in
Is TherapeuticsMD Inc. stock a buy before product launchesWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Is TherapeuticsMD Inc. (29TA) stock supported by strong fundamentalsAnalyst Downgrade & Expert Curated Trade Ideas - newser.com
Can TherapeuticsMD Inc. stock hit analyst price targets2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Therapeuticsmd Inc (TXMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Therapeuticsmd Inc 주식 (TXMD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Thompson Tommy G | Director |
Apr 14 '25 |
Buy |
1.00 |
325 |
326 |
14,779 |
| Walker Marlan D | Chief Executive Officer |
Apr 14 '25 |
Buy |
1.00 |
490 |
489 |
73,639 |
| Walker Marlan D | Chief Executive Officer |
Apr 10 '25 |
Buy |
0.86 |
1,167 |
1,000 |
73,149 |
| Walker Marlan D | Chief Executive Officer |
Apr 09 '25 |
Buy |
0.87 |
1,136 |
994 |
71,982 |
| Collins Cooper C. | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
60,516 |
| Naughton Gail K | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
8,500 |
| Thompson Tommy G | Director |
Feb 18 '25 |
Option Exercise |
0.00 |
8,500 |
0 |
14,454 |
| Walker Marlan D | Chief Executive Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
8,281 |
0 |
70,846 |
4.03%
2.38%
자본화:
|
볼륨(24시간):